- Home
- CNOBP vs BBIO Comparison
CNOBP vs BBIO Comparison
Compare CNOBP & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNOBP
- BBIO
- Stock Information
- Founded
- CNOBP N/A
- BBIO 2015
- Country
- CNOBP United States
- BBIO United States
- Employees
- CNOBP 493
- BBIO N/A
- Industry
- CNOBP Major Banks
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CNOBP Finance
- BBIO Health Care
- Exchange
- CNOBP Nasdaq
- BBIO Nasdaq
- Market Cap
- CNOBP N/A
- BBIO 6.7B
- IPO Year
- CNOBP N/A
- BBIO 2019
- Fundamental
- Price
- CNOBP $22.40
- BBIO $34.83
- Analyst Decision
- CNOBP
- BBIO Strong Buy
- Analyst Count
- CNOBP 0
- BBIO 12
- Target Price
- CNOBP N/A
- BBIO $57.09
- AVG Volume (30 Days)
- CNOBP N/A
- BBIO 3.2M
- Earning Date
- CNOBP N/A
- BBIO 04-29-2025
- Dividend Yield
- CNOBP N/A
- BBIO N/A
- EPS Growth
- CNOBP N/A
- BBIO N/A
- EPS
- CNOBP N/A
- BBIO N/A
- Revenue
- CNOBP N/A
- BBIO $127,415,000.00
- Revenue This Year
- CNOBP N/A
- BBIO $13.67
- Revenue Next Year
- CNOBP N/A
- BBIO $118.02
- P/E Ratio
- CNOBP N/A
- BBIO N/A
- Revenue Growth
- CNOBP N/A
- BBIO N/A
- 52 Week Low
- CNOBP N/A
- BBIO $21.62
- 52 Week High
- CNOBP N/A
- BBIO $39.47
- Technical
- Relative Strength Index (RSI)
- CNOBP 56.27
- BBIO 46.94
- Support Level
- CNOBP $22.39
- BBIO $36.85
- Resistance Level
- CNOBP $22.64
- BBIO $39.16
- Average True Range (ATR)
- CNOBP 0.15
- BBIO 1.47
- MACD
- CNOBP 0.09
- BBIO -0.07
- Stochastic Oscillator
- CNOBP 75.76
- BBIO 25.61
About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.